- Between 2000 to 2015, deaths from Alzheimer’s disease have increase by over 123%
- 1 in 3 seniors die with Alzheimer’s or another form of dementia
- Infographic provided by the Alzheimer’s Association
BioViva and its partner company Integrated Health Systems (IHS) is also doing its part in testing its new telomerase gene therapy to tackle the disease. IHS is building upon mounting research evidence that points to the association of shorter telomere length, i.e. the ends of our chromosomes, to Alzheimer’s. This reduction in telomere length can be dealt with by induction of an enzyme called telomerase.
Go go this link to find out more about IHS’s Alzheimier’s Disease trials, and to schedule a consultation: https://www.integrated-health-systems.com/specialist-areas/alzheimers/